Evidence map›Paper›PMID 31974654›Full record

ArticleCellular and molecular life sciences : CMLS2020

A SYK/SHC1 pathway regulates the amount of CFTR in the plasma membrane.

Cláudia Almeida Loureiro, Francisco R Pinto, Patrícia Barros, Paulo Matos, Peter Jordan

Erratum issuedOpen access · greenAbstract read
In one paragraph

Article in Cellular and molecular life sciences : CMLS, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.3field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Cell type-specific regulation of CFTR trafficking-on the verge of progress.Frontiers in cell and developmental biology · 2024
    Review
  5. Article
  6. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Cláudia Almeida LoureiroDepartment of Human Genetics, National Health Institute 'Dr. Ricardo Jorge', Avenida Padre Cruz, 1649-016, Lisbon, Portugal.ORCID http://orcid.org/0000-0002-6969-3285
Francisco R PintoBioISI-Biosystems and Integrative Sciences Institute, Faculty of Sciences, University of Lisbon, Lisbon, Portugal.ORCID http://orcid.org/0000-0002-4217-0054
Patrícia BarrosDepartment of Human Genetics, National Health Institute 'Dr. Ricardo Jorge', Avenida Padre Cruz, 1649-016, Lisbon, Portugal.ORCID http://orcid.org/0000-0001-5063-5766
Paulo MatosDepartment of Human Genetics, National Health Institute 'Dr. Ricardo Jorge', Avenida Padre Cruz, 1649-016, Lisbon, Portugal.ORCID http://orcid.org/0000-0002-9379-9696
Peter JordanDepartment of Human Genetics, National Health Institute 'Dr. Ricardo Jorge', Avenida Padre Cruz, 1649-016, Lisbon, Portugal. peter.jordan@insa.min-saude.pt.ORCID http://orcid.org/0000-0002-1425-9211
University of Lisbon · PT

Funding

Fundação para a Ciência e a Tecnologia PTDC/BIA-CEL/28408/2017Fundação para a Ciência e a Tecnologia SFRH/BD/52488/2014Fundação para a Ciência e a Tecnologia SFRH/BPD/94322/2013Fundação para a Ciência e a Tecnologia UID/MULTI/04046/2013
6 · The paper itself

Abstract

Mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene cause the recessive genetic disease cystic fibrosis, where the chloride transport across the apical membrane of epithelial cells mediated by the CFTR protein is impaired. CFTR protein trafficking to the plasma membrane (PM) is the result of a complex interplay between the secretory and membrane recycling pathways that control the number of channels present at the membrane. In addition, the ion transport activity of CFTR at the PM is modulated through post-translational protein modifications. Previously we described that spleen tyrosine kinase (SYK) phosphorylates a specific tyrosine residue in the nucleotide-binding domain 1 domain and this modification can regulate the PM abundance of CFTR. Here we identified the underlying biochemical mechanism using peptide pull-down assays followed by mass spectrometry. We identified in bronchial epithelial cells that the adaptor protein SHC1 recognizes tyrosine-phosphorylated CFTR through its phosphotyrosine-binding domain and that the formation of a complex between SHC1 and CFTR is induced at the PM in the presence of activated SYK. The depletion of endogenous SHC1 expression was sufficient to promote an increase in CFTR at the PM of these cells. The results identify a SYK/SHC1 pathway that regulates the PM levels of CFTR channels, contributing to a better understanding of how CFTR-mediated chloride secretion is regulated.

Indexed as

Signal TransductionBiological TransportCell LineCell MembraneChloridesCystic Fibrosis Transmembrane Conductance RegulatorEpithelial CellsHumansLungPhosphopeptidesPhosphorylationPhosphotyrosineProtein BindingProtein DomainsProtein Interaction MapsProtein Kinase InhibitorsChloridesCystic Fibrosis Transmembrane Conductance RegulatorPhosphopeptidesPhosphotyrosineProtein Kinase InhibitorsSHC1 protein, humanSrc Homology 2 Domain-Containing, Transforming Protein 1Syk KinaseSYK protein, humanCFTRChloride co-transportMembrane trafficProtein phosphorylationSHC1SYK

Identifiers

PMID31974654
PMCPMC11105000
OpenAlexW3001264329

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.